Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries AbbVie (NY: ABBV ) 161.95 +1.14 (+0.71%) Streaming Delayed Price Updated: 10:48 AM EDT, May 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about AbbVie < Previous 1 2 3 4 5 6 7 8 9 ... 53 54 Next > Better Dividend Growth Stock: AbbVie or Amgen? February 29, 2024 A strong case can be made for owning both of these dividend growth stocks. But one of them is the better buy. Via The Motley Fool Is AbbVie Stock a Buy Now? February 29, 2024 Some would say the growth story is over, but that view might be a bit myopic. Via The Motley Fool Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years February 28, 2024 Via Benzinga 3 Magnificent Dividend Growth Stocks to Buy Now and Hold for at Least a Decade February 27, 2024 These stocks don't offer the highest yields, but their payouts are growing fast. Via The Motley Fool Why Is Generic Drugs Player Teva Pharma Stock Trading Higher Today? February 26, 2024 FDA-approved Simlandi (adalimumab-ryvk): a high-concentration biosimilar to Humira for rheumatoid arthritis, psoriasis, and more. Via Benzinga 3 Dividend Stocks That Are No-Brainer Buys Right Now February 24, 2024 These stocks check off multiple boxes for investors. Via The Motley Fool AbbVie Stock Clears Key Benchmark, Hitting 80-Plus RS Rating February 14, 2024 A Relative Strength Rating upgrade for AbbVie shows improving technical performance. Via Investor's Business Daily AbbVie Options Trading: A Deep Dive into Market Sentiment February 07, 2024 Via Benzinga $100 Invested In AbbVie 10 Years Ago Would Be Worth This Much Today February 06, 2024 Via Benzinga Is AbbVie Stock a Buy Now? February 22, 2024 Management pivoting a $300 billion company as quickly as it has is nothing short of remarkable. Via The Motley Fool 5 Forever Dividend Stocks to Build Your Portfolio February 20, 2024 These five stocks are high quality and reliable. Via The Motley Fool 3 Magnificent Growth Stocks to Buy Right Now February 19, 2024 These stocks share at least two common denominators: a biopharmaceutical focus and great long-term prospects. Via The Motley Fool 3 Cash Cows to Boost Your Confidence During the February Chill February 18, 2024 The market can be a tricky place. Bet on these cash cow stocks to help restore confidence and extract steady returns. Via InvestorPlace Beyond Nvidia: How To Navigate Investing In Your 40s — Insights From Reddit February 14, 2024 A Reddit user reached out to the community seeking advice beyond the hunt for the "next NVIDIA Corp." Here's a sample of the responses. Via Benzinga 2 Magnificent Dividend Growth Stocks to Load Up On Right Now February 06, 2024 These two dividend-growth stocks are fantastic buys. Via The Motley Fool AbbVie Analysts Boost Their Forecasts Following Strong Earnings February 05, 2024 AbbVie Inc (NYSE: ABBV) reported better-than-expected fourth-quarter earnings on Friday. Via Benzinga The 7 Best Momentum Stocks You Can Purchase Today February 12, 2024 If you’re looking for hot opportunities in the market, here are just a few of the best momentum stocks to buy today. Via InvestorPlace Is It Too Late to Buy These 2 Brilliant Passive Income Stocks? February 12, 2024 These incredible businesses have long histories of successes behind them, and more to come. Via The Motley Fool These 17 Words From AbbVie's CEO Explain Why the Stock Is Still a Buy February 11, 2024 The drugmaker is handling its biggest obstacle yet relatively well. Via The Motley Fool Jim Cramer Looks At Blackstone, Praises MercadoLibre: 'They're Incredibly Smart' February 09, 2024 On CNBC’s "Mad Money Lightning Round," Jim Cramer said Freeport-McMoRan Inc. (NYSE: FCX) could go higher by a "couple of points, once the Chinese start manipulating their market higher, but that’s all... Via Benzinga 3 Stocks Just Hit New 52-Week Highs. Should You Still Be Buying? February 08, 2024 Letting your winners run is a proven way to generate extraordinary portfolio returns without cutting them off by taking profits. Via InvestorPlace 3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List February 06, 2024 These biotech stocks offer investors huge potential in the future. Investors may want to consider these equities to enter the industry. Via InvestorPlace 7 Russell 2000 Stocks to Buy for the Next Bull Run: February 2024 February 06, 2024 Unveil these standout Russell 2000 stocks, meticulously picked to harness the potential of the evolving market landscape in the 2024 surge. Via InvestorPlace UBS Bullish On This Depression Drug Maker, Says Alzheimer's Agitation Data Is Attractive Catalyst February 06, 2024 UBS bullish on Axsome's Auvelity launch and pipeline, foreseeing $1 billion sales by 2030. Buy rating, $111 price target. Positive Phase 3 data for Alzheimer's Agitation and Narcolepsy. Via Benzinga 7 Dividend Stocks Worth Holding for the Long Haul February 06, 2024 These dividend stocks are worth holding for the long term both for upside and income production that can add up quickly. Via InvestorPlace Why AbbVie Stock Flew Higher on Monday February 05, 2024 Investors and pundits alike continued to be impressed by the company's latest earnings report. Via The Motley Fool Drug Maker AbbVie Stock Sees RS Rating Jump To 81 February 05, 2024 AbbVie stock saw a welcome improvement to its Relative Strength (RS) Rating on Monday, with an increase from 78 to 81. Via Investor's Business Daily Better Dividend Stock: Pfizer vs. AbbVie February 05, 2024 Both offer above-average yields but which can deliver the most dividend income over the long run? Via The Motley Fool Pinterest To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Monday February 05, 2024 Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Via Benzinga 3 Fabulous Dividend Stocks to Buy in February February 04, 2024 These stocks offer great dividends and more. Via The Motley Fool < Previous 1 2 3 4 5 6 7 8 9 ... 53 54 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.